{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:35:48Z","timestamp":1793414148785,"version":"4.5.0"},"reference-count":90,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo (FAPESP)","doi-asserted-by":"publisher","award":["2013\/50450-2"],"award-info":[{"award-number":["2013\/50450-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo (FAPESP)","doi-asserted-by":"publisher","award":["2013\/50764-7"],"award-info":[{"award-number":["2013\/50764-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo (FAPESP)","doi-asserted-by":"publisher","award":["2014\/15846-5"],"award-info":[{"award-number":["2014\/15846-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo (FAPESP)","doi-asserted-by":"publisher","award":["2024\/06402-8"],"award-info":[{"award-number":["2024\/06402-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo (FAPESP)","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP-MIT program","doi-asserted-by":"publisher","award":["2013\/50450-2"],"award-info":[{"award-number":["2013\/50450-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP-MIT program","doi-asserted-by":"publisher","award":["2013\/50764-7"],"award-info":[{"award-number":["2013\/50764-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP-MIT program","doi-asserted-by":"publisher","award":["2014\/15846-5"],"award-info":[{"award-number":["2014\/15846-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP-MIT program","doi-asserted-by":"publisher","award":["2024\/06402-8"],"award-info":[{"award-number":["2024\/06402-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP-MIT program","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP doctoral fellowship","doi-asserted-by":"publisher","award":["2013\/50450-2"],"award-info":[{"award-number":["2013\/50450-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP doctoral fellowship","doi-asserted-by":"publisher","award":["2013\/50764-7"],"award-info":[{"award-number":["2013\/50764-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP doctoral fellowship","doi-asserted-by":"publisher","award":["2014\/15846-5"],"award-info":[{"award-number":["2014\/15846-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP doctoral fellowship","doi-asserted-by":"publisher","award":["2024\/06402-8"],"award-info":[{"award-number":["2024\/06402-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP doctoral fellowship","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"name":"S\u00e3o Paulo Research Foundation","award":["2013\/50450-2"],"award-info":[{"award-number":["2013\/50450-2"]}]},{"name":"S\u00e3o Paulo Research Foundation","award":["2013\/50764-7"],"award-info":[{"award-number":["2013\/50764-7"]}]},{"name":"S\u00e3o Paulo Research Foundation","award":["2014\/15846-5"],"award-info":[{"award-number":["2014\/15846-5"]}]},{"name":"S\u00e3o Paulo Research Foundation","award":["2024\/06402-8"],"award-info":[{"award-number":["2024\/06402-8"]}]},{"name":"S\u00e3o Paulo Research Foundation","award":["001"],"award-info":[{"award-number":["001"]}]},{"DOI":"10.13039\/501100003593","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["2013\/50450-2"],"award-info":[{"award-number":["2013\/50450-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["2013\/50764-7"],"award-info":[{"award-number":["2013\/50764-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["2014\/15846-5"],"award-info":[{"award-number":["2014\/15846-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["2024\/06402-8"],"award-info":[{"award-number":["2024\/06402-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["2013\/50450-2"],"award-info":[{"award-number":["2013\/50450-2"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["2013\/50764-7"],"award-info":[{"award-number":["2013\/50764-7"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["2014\/15846-5"],"award-info":[{"award-number":["2014\/15846-5"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["2024\/06402-8"],"award-info":[{"award-number":["2024\/06402-8"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"Foundation for Support to Teaching, Research, and Assistance of the HC-FMRP-USP (FAEPA)","award":["2013\/50450-2"],"award-info":[{"award-number":["2013\/50450-2"]}]},{"name":"Foundation for Support to Teaching, Research, and Assistance of the HC-FMRP-USP (FAEPA)","award":["2013\/50764-7"],"award-info":[{"award-number":["2013\/50764-7"]}]},{"name":"Foundation for Support to Teaching, Research, and Assistance of the HC-FMRP-USP (FAEPA)","award":["2014\/15846-5"],"award-info":[{"award-number":["2014\/15846-5"]}]},{"name":"Foundation for Support to Teaching, Research, and Assistance of the HC-FMRP-USP (FAEPA)","award":["2024\/06402-8"],"award-info":[{"award-number":["2024\/06402-8"]}]},{"name":"Foundation for Support to Teaching, Research, and Assistance of the HC-FMRP-USP (FAEPA)","award":["001"],"award-info":[{"award-number":["001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Gaucher disease (GD) is an autosomal recessive disorder caused by the deficient activity of the lysosomal enzyme glucocerebrosidase (GCase). Although enzyme replacement therapy (ERT) remains the standard of care for non-neuropathic GD patients, its high cost significantly limits accessibility. To enhance production efficiency, we developed a lentiviral system encoding a codon-optimized GCase gene driven by the human elongation factor 1a (hEF1\u03b1) promoter for stable production in human cell lines. A functional lentiviral vector, LV_EF1\u03b1_GBA_Opt, was generated at a titer of 7.88 \u00d7 108 LV particles\/mL as determined by qPCR. Six transduction cycles were performed at a multiplicity of infection of 30\u201350. The transduced heterogeneous human cell population showed GCase-specific activity of 307.5 \u00b1 53.49 nmol\/mg protein\/h, which represents a 3.21-fold increase compared to wild-type 293FT cells (95.58 \u00b1 16.5 nmol\/mg protein\/h). Following single-cell cloning, two clones showed specific activity of 763.8 \u00b1 135.1 and 752.0 \u00b1 152.1 nmol\/mg\/h (clones 15 and 16, respectively). These results show that codon optimization, a lentiviral delivery system, and clonal selection together enable the establishment of stable human cell lines capable of producing high levels of biologically active, synthetic recombinant GCase in vitro. Further studies are warranted for the functional validation in GD patient-derived fibroblasts and animal models.<\/jats:p>","DOI":"10.3390\/ijms26157089","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T11:52:47Z","timestamp":1753271567000},"page":"7089","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of a Lentiviral Vector for High-Yield Production of Synthetic and Recombinant GCase for Gaucher Disease Therapy"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0307-1503","authenticated-orcid":false,"given":"Ana Carolina","family":"Coelho","sequence":"first","affiliation":[{"name":"Department of Genetics, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4381-0834","authenticated-orcid":false,"given":"Claudia Em\u00edlia Vieira","family":"Wiezel","sequence":"additional","affiliation":[{"name":"Department of Genetics, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4258-3198","authenticated-orcid":false,"given":"Alline Cristina","family":"de Campos","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edlian Louise Souza","family":"Figueiredo","sequence":"additional","affiliation":[{"name":"Department of Genetics, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2735-2570","authenticated-orcid":false,"given":"Gabriela Aparecida Marcondes","family":"Suardi","sequence":"additional","affiliation":[{"name":"Department of Genetics, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9542-5495","authenticated-orcid":false,"given":"Juliana","family":"de Paula Bernardes","sequence":"additional","affiliation":[{"name":"Department of Genetics, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Pretti","family":"da Cunha Tirapelli","sequence":"additional","affiliation":[{"name":"Department of Surgery and Anatomy, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3205-7944","authenticated-orcid":false,"given":"Vitor Marcel","family":"Fa\u00e7a","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0520-4665","authenticated-orcid":false,"given":"Kuruvilla Joseph","family":"Abraham","sequence":"additional","affiliation":[{"name":"Department of Computer Science, Institute of Mathematics and Computer Science, University of S\u00e3o Paulo, S\u00e3o Carlos 13566-590, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Gilberto","family":"Carlotti-J\u00fanior","sequence":"additional","affiliation":[{"name":"Division of Neurology, S\u00e3o Paulo Medical School, University of S\u00e3o Paulo, S\u00e3o Paulo 05403-000, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7734-9153","authenticated-orcid":false,"given":"Velia","family":"Siciliano","sequence":"additional","affiliation":[{"name":"Synthetic and Systems Biology Laboratory for Biomedicine, Istituto Italiano di Tecnologia-IIT, Largo Barsanti e Matteucci, 80125 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Weiss","sequence":"additional","affiliation":[{"name":"Synthetic Biology Center, Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02129-4307, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3106-2549","authenticated-orcid":false,"given":"Stanton","family":"Gerson","sequence":"additional","affiliation":[{"name":"School of Medicine, University Hospital Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-417X","authenticated-orcid":false,"given":"Aparecida Maria","family":"Fontes","sequence":"additional","affiliation":[{"name":"Department of Genetics, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo, Ribeir\u00e3o Preto 14049-900, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"ref_1","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). Gaucher Disease. GeneReviews((R)), University of Washington."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-291X(65)90743-6","article-title":"Metabolism of Glucocerebrosides. Ii. Evidence of an Enzymatic Deficiency in Gaucher\u2019s Disease","volume":"18","author":"Brady","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Elstein, D., Belmatoug, N., Bembi, B., Deegan, P., Fernandez-Sasso, D., Giraldo, P., Goker-Alpan, O., Hughes, D., Lau, H., and Lukina, E. (2024). Twelve Years of the Gaucher Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global Patient Registry. J. Clin. Med., 13.","DOI":"10.3390\/jcm13123588"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/hmg\/ddaf045","article-title":"Modeling bone marrow microenvironment and hematopoietic dysregulation in Gaucher disease through VavCre mediated Gba deletion","volume":"34","author":"Belinsky","year":"2025","journal-title":"Hum. Mol. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00109-024-02512-x","article-title":"Deciphering metabolic shifts in Gaucher disease type 1: A multi-omics study","volume":"103","author":"Ducatez","year":"2025","journal-title":"J. Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher\u2019s disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Cohen, D., Levy, Y., Bar-Ziv, Y., Revel-Vilk, S., Zimran, A., and Lebel, E. (2023). Simultaneous Bilateral Femoral Osteonecrosis in Gaucher Disease. Life, 13.","DOI":"10.3390\/life13051135"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2020.12.291","article-title":"Gaucher disease: Basic and translational science needs for more complete therapy and management","volume":"132","author":"Grabowski","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"109074","DOI":"10.1016\/j.ymgme.2025.109074","article-title":"Challenges in Gaucher disease: Perspectives from an expert panel","volume":"145","author":"Grabowski","year":"2025","journal-title":"Mol. Genet. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Furderer, M.L., Hertz, E., Lopez, G.J., and Sidransky, E. (2022). Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105842"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41582-024-00999-z","article-title":"Gaucher disease provides a unique window into Parkinson disease pathogenesis","volume":"20","author":"Hertz","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1007\/s00415-024-12439-5","article-title":"Neurological symptoms in adults with Gaucher disease: A systematic review","volume":"271","author":"Imbalzano","year":"2024","journal-title":"J. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1007\/s00277-024-05918-2","article-title":"Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease","volume":"103","author":"Motta","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Deegan, P., Lau, H., Elstein, D., Fernandez-Sasso, D., Giraldo, P., Hughes, D., Zimran, A., Istaiti, M., Gadir, N., and Botha, J. (2024). Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naive Patients from the Gaucher Outcome Survey (GOS) Registry. J. Clin. Med., 13.","DOI":"10.3390\/jcm13102782"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Revel-Vilk, S., Mansfield, R., Feder-Krengel, N., Machtiger-Azoulay, N., Kuter, D., Szer, J., Rosenbaum, H., Ferreira, D.C., Ruhrman-Shahar, N., and Wajnrajch, M. (2023). Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185913"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ain, N.U., Saith, A., Ruan, A., Yang, R., Burton, A., and Mistry, P.K. (2025). Eliglustat substrate reduction therapy in children with Gaucher disease type 1. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1543136"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/ajh.27347","article-title":"Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher Registry","volume":"99","author":"Mistry","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014Macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymgme.2020.12.295","article-title":"International Collaborative Gaucher Group Gaucher Registry i: Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment","volume":"132","author":"Weinreb","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1002\/ajh.24055","article-title":"Understanding the natural history of Gaucher disease","volume":"90","author":"Mistry","year":"2015","journal-title":"Am. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Stepien, K.M., Kiec-Wilk, B., Lampe, C., Tangeraas, T., Cefalo, G., Belmatoug, N., Francisco, R., Del Toro, M., Wagner, L., and Lauridsen, A.G. (2021). Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey. Front. Med., 8.","DOI":"10.3389\/fmed.2021.652358"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Borin, M.C., Alvares-Teodoro, J., Acurcio, F.A., and Guerra, A.A. (2024). Gaucher disease in Brazil: A comprehensive 16 year retrospective study on survival, cost, and treatment insights. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1433970"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: Comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0140-6736(95)91038-7","article-title":"Replacement therapy with imiglucerase for type 1 Gaucher\u2019s disease","volume":"345","author":"Zimran","year":"1995","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-02-268649","article-title":"Phase 1\/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experience","volume":"115","author":"Zimran","year":"2010","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1358\/dot.2011.47.7.1608922","article-title":"Velaglucerase alfa: A new option for Gaucher disease treatment","volume":"47","author":"Zimran","year":"2011","journal-title":"Drugs Today"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1182\/blood-2011-07-366955","article-title":"Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bcmd.2012.11.001","article-title":"Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease","volume":"50","author":"Zimran","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_30","unstructured":"Brasil, Minist\u00e9rio da Sa\u00fade, and Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade (2014). Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Doen\u00e7a de Gaucher."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s001090050279","article-title":"Long-term expression and secretion of human glucocerebrosidase by primary murine and human myoblasts and differentiated myotubes","volume":"76","author":"Liu","year":"1998","journal-title":"J. Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbrc.2004.04.040","article-title":"Expression and secretion of human glucocerebrosidase mediated by recombinant lentivirus vectors in vitro and in vivo: Implications for gene therapy of Gaucher disease","volume":"318","author":"Kim","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1038\/s41467-020-17148-x","article-title":"Engineering monocyte\/macrophage-specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing","volume":"11","author":"Scharenberg","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Novo, J.B., Morganti, L., Moro, A.M., Paes Leme, A.F., Serrano, S.M., Raw, I., and Ho, P.L. (2012). Generation of a Chinese hamster ovary cell line producing recombinant human glucocerebrosidase. J. Biomed. Biotechnol., 2012.","DOI":"10.1155\/2012\/875383"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Naphatsamon, U., Ohashi, T., Misaki, R., and Fujiyama, K. (2018). The Production of Human beta-Glucocerebrosidase in Nicotiana benthamiana Root Culture. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19071972"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jbiosc.2022.01.002","article-title":"Production of recombinant beta-glucocerebrosidase in wild-type and glycoengineered transgenic Nicotiana benthamiana root cultures with different N-glycan profiles","volume":"133","author":"Uthailak","year":"2022","journal-title":"J. Biosci. Bioeng."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e48220","DOI":"10.15252\/embr.201948220","article-title":"Codon bias confers stability to human mRNAs","volume":"20","author":"Hia","year":"2019","journal-title":"EMBO Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"D76","DOI":"10.1093\/nar\/gkl648","article-title":"SGDB: A database of synthetic genes re-designed for optimizing protein over-expression","volume":"35","author":"Wu","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2899","article-title":"Synonymous but not the same: The causes and consequences of codon bias","volume":"12","author":"Plotkin","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/hum.2017.116","article-title":"Hemophilia Gene Therapy: Ready for Prime Time?","volume":"28","author":"VandenDriessche","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa2410597","article-title":"Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A","volume":"392","author":"Srivastava","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.omtm.2018.03.002","article-title":"Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency","volume":"9","author":"Poletti","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Banning, A., Konig, J.F., Gray, S.J., and Tikkanen, R. (2017). Functional Analysis of the Ser149\/Thr149 Variants of Human Aspartylglucosaminidase and Optimization of the Coding Sequence for Protein Production. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18040706"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41434-022-00381-y","article-title":"Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease","volume":"30","author":"Jeyakumar","year":"2023","journal-title":"Gene Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1046-5928(02)00526-0","article-title":"Synonymous codon usage bias and the expression of human glucocerebrosidase in the methylotrophic yeast, Pichia pastoris","volume":"26","author":"Sinclair","year":"2002","journal-title":"Protein Expr. Purif."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s42452-024-06227-z","article-title":"Engineering Synthetic and Recombinant Human Lysosomal \u03b2-Glucocerebrosidase for Enzyme Replacement Therapy for Gaucher Disease","volume":"6","author":"Figueiredo","year":"2024","journal-title":"Discov. Appl. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/bab.1660","article-title":"Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris","volume":"65","author":"Pimentel","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1089\/hum.2022.141","article-title":"Phenotypic Correction of Murine Mucopolysaccharidosis Type II by Engraftment of Ex vivo Lentiviral Vector-Transduced Hematopoietic Stem and Progenitor Cells","volume":"33","author":"Smith","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/hum.2019.008","article-title":"An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice","volume":"30","author":"Pan","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15038","DOI":"10.1038\/mtm.2015.38","article-title":"Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy","volume":"2","author":"Ungari","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/hum.2015.103","article-title":"Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease","volume":"27","author":"Doerfler","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.omtm.2020.04.023","article-title":"Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease","volume":"17","author":"Stok","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.omtm.2022.09.010","article-title":"IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy","volume":"27","author":"Liang","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ornaghi, F., Sala, D., Tedeschi, F., Maffia, M.C., Bazzucchi, M., Morena, F., Valsecchi, M., Aureli, M., Martino, S., and Gritti, A. (2020). Novel bicistronic lentiviral vectors correct beta-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: Implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis. Neurobiol. Dis., 134.","DOI":"10.1016\/j.nbd.2019.104667"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101445","DOI":"10.1016\/j.gendis.2024.101445","article-title":"Preclinical ex vivo IL2RG gene therapy using autologous hematopoietic stem cells as an effective and safe treatment for X-linked severe combined immunodeficiency disease","volume":"12","author":"Hu","year":"2025","journal-title":"Genes Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.omtm.2023.01.003","article-title":"Persistent hematopoietic polyclonality after lentivirus-mediated gene therapy for Fabry disease","volume":"28","author":"Saleh","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.stemcr.2021.04.011","article-title":"Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes","volume":"16","author":"Mangiameli","year":"2021","journal-title":"Stem Cell Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"101271","DOI":"10.1016\/j.omtm.2024.101271","article-title":"Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy","volume":"32","author":"Ellison","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.omtm.2022.10.017","article-title":"Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease","volume":"27","author":"Dogan","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_60","first-page":"53","article-title":"Gene therapy for inherited metabolic diseases","volume":"24","author":"Yilmaz","year":"2020","journal-title":"J. Mother Child"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1525-0016(03)00005-4","article-title":"Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD\/SCID repopulating cells","volume":"7","author":"Zielske","year":"2003","journal-title":"Mol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1158\/1535-7163.MCT-05-0236","article-title":"Differential competitive resistance to methylating versus chloroethylating agents among five O6-alkylguanine DNA alkyltransferases in human hematopoietic cells","volume":"5","author":"Fontes","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4238\/2012.March.22.8","article-title":"Production of human factor VIII-FL in 293T cells using the bicistronic MGMT(P140K)-retroviral vector","volume":"11","author":"Fontes","year":"2012","journal-title":"Genet. Mol. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10529-014-1764-2","article-title":"Significant differences in integration sites of Moloney murine leukemia virus\/Moloney murine sarcoma virus retroviral vector carrying recombinant coagulation factor IX in two human cell lines","volume":"37","author":"Fontes","year":"2015","journal-title":"Biotechnol. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bjhh.2014.03.002","article-title":"Murine leukemia virus-derived retroviral vector has differential integration patterns in human cell lines used to produce recombinant factor VIII","volume":"36","author":"Fontes","year":"2014","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical use of lentiviral vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.aah6192","article-title":"Lentiviral vectors, two decades later","volume":"353","author":"Naldini","year":"2016","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41576-025-00827-0","article-title":"Challenges and solutions to the sustainability of gene and cell therapies","volume":"26","author":"Scotti","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jgm.1052","article-title":"Optimized production and concentration of lentiviral vectors containing large inserts","volume":"9","author":"Romanowska","year":"2007","journal-title":"J. Gene Med."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Hirch, T., Brander, N., Schenk, F., Pollmann, S.J., Reichenbach, J., Schubert, R., and Modlich, U. (2023). Expression of a large coding sequence. Gene therapy vectors for Ataxia Telangiectasia. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-46332-4"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wang, Z., Chen, C., and Ge, X. (2024). Large T antigen mediated target gene replication improves site-specific recombination efficiency. Front. Bioeng. Biotechnol., 12.","DOI":"10.3389\/fbioe.2024.1377167"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Abaandou, L., Quan, D., and Shiloach, J. (2021). Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific Genes. Cells, 10.","DOI":"10.3390\/cells10071667"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: A vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Perry, C., and Rayat, A. (2021). Lentiviral Vector Bioprocessing. Viruses, 13.","DOI":"10.3390\/v13020268"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Jargalsaikhan, B.E., Muto, M., Been, Y., Matsumoto, S., Okamura, E., Takahashi, T., Narimichi, Y., Kurebayashi, Y., Takeuchi, H., and Shinohara, T. (2024). The Dual-Pseudotyped Lentiviral Vector with VSV-G and Sendai Virus HN Enhances Infection Efficiency through the Synergistic Effect of the Envelope Proteins. Viruses, 16.","DOI":"10.3390\/v16060827"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s40001-025-02499-2","article-title":"Development and validation of optimized lentivirus-like particles for gene editing tool delivery with Gag-Only strategy","volume":"30","author":"Jia","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cels.2022.11.005","article-title":"The sound of silence: Transgene silencing in mammalian cell engineering","volume":"13","author":"Cabrera","year":"2022","journal-title":"Cell Syst."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/21655979.2019.1684863","article-title":"Effect of promoter, promoter mutation and enhancer on transgene expression mediated by episomal vectors in transfected HEK293, Chang liver and primary cells","volume":"10","author":"Xu","year":"2019","journal-title":"Bioengineered"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(21)02017-1","article-title":"Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: Long-term results from a non-randomised, open-label, phase 1\/2 trial and expanded access","volume":"399","author":"Fumagalli","year":"2022","journal-title":"Lancet"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"105037","DOI":"10.1016\/j.jprot.2023.105037","article-title":"Lentiviral gene therapy with IGF2-tagged GAA normalizes the skeletal muscle proteome in murine Pompe disease","volume":"291","author":"Liang","year":"2024","journal-title":"J. Proteom."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s10529-012-0925-4","article-title":"SK-HEP cells and lentiviral vector for production of human recombinant factor VIII","volume":"34","author":"Swiech","year":"2012","journal-title":"Biotechnol. Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.trsl.2016.02.001","article-title":"In vitro expansion of human cardiac progenitor cells: Exploring \u2018omics tools for characterization of cell-based allogeneic products","volume":"171","author":"Serra","year":"2016","journal-title":"Transl. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e2410510","DOI":"10.1002\/advs.202410510","article-title":"Billion-Scale Expansion of Functional hiPSC-Derived Cardiomyocytes in Bioreactors Through Oxygen Control and Continuous Wnt Activation","volume":"12","author":"Vicente","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/mt.2010.239","article-title":"Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII","volume":"19","author":"Spencer","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nprot.2009.22","article-title":"Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors","volume":"4","author":"Kutner","year":"2009","journal-title":"Nat. Protoc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bjhh.2016.04.002","article-title":"The F309S mutation increases factor VIII secretion in human cell line","volume":"38","author":"Fantacini","year":"2016","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1634\/stemcells.2006-0699","article-title":"Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors","volume":"25","author":"Matsui","year":"2007","journal-title":"Stem Cells"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0003-9861(76)90547-6","article-title":"Differentiation of beta-glucocerebrosidase from beta-glucosidase in human tissues using sodium taurocholate","volume":"175","author":"Peters","year":"1976","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1746-1596-5-65","article-title":"Reference values for lysosomal enzymes activities using dried blood spots samples\u2014A Brazilian experience","volume":"5","author":"Muller","year":"2010","journal-title":"Diagn. Pathol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7089\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:35Z","timestamp":1760033675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":90,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157089"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157089","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}